Skip to content

Copper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate)

C44H40CuN6O4S2 — CID 139121066

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACcopper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate)
SMILESCOc1cc(-c2nc3ccccc3s2)cc(CN(C)Cc2ccccn2)c1[O-].COc1cc(-c2nc3ccccc3s2)cc(CN(C)Cc2ccccn2)c1[O-].[Cu+2]
InChIInChI=1S/2C22H21N3O2S.Cu/c2*1-25(14-17-7-5-6-10-23-17)13-16-11-15(12-19(27-2)21(16)26)22-24-18-8-3-4-9-20(18)28-22;/h2*3-12,26H,13-14H2,1-2H3;/q;;+2/p-2
InChIKeyMCEIGWQQZDDKGS-UHFFFAOYSA-L
MW844.52 g/mol
LogP8.14
Rot. Bonds12

About Copper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate)

Copper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate) (PubChem CID 139121066) has the molecular formula C44H40CuN6O4S2 and a molecular weight of 844.52 g/mol. Its IUPAC name is copper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate).

Molecular Properties

Compound NameCopper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate)
PubChem CID139121066
Molecular FormulaC44H40CuN6O4S2
Molecular Weight844.52 g/mol
Exact Mass843.18
IUPAC Namecopper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate)
SMILESCOc1cc(-c2nc3ccccc3s2)cc(CN(C)Cc2ccccn2)c1[O-].COc1cc(-c2nc3ccccc3s2)cc(CN(C)Cc2ccccn2)c1[O-].[Cu+2]
InChIInChI=1S/2C22H21N3O2S.Cu/c2*1-25(14-17-7-5-6-10-23-17)13-16-11-15(12-19(27-2)21(16)26)22-24-18-8-3-4-9-20(18)28-22;/h2*3-12,26H,13-14H2,1-2H3;/q;;+2/p-2
InChIKeyMCEIGWQQZDDKGS-UHFFFAOYSA-L
XLogP8.14
TPSA122.62 Ų
H-Bond Donors
H-Bond Acceptors12
Rotatable Bonds12
Heavy Atoms57
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500844.52
LogP ≤ 58.14
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1012

Analyze Copper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Copper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate)?
The IUPAC name of Copper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate) (CID 139121066) is copper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate).
What is the SMILES notation for Copper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate)?
The canonical SMILES for Copper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate) is COc1cc(-c2nc3ccccc3s2)cc(CN(C)Cc2ccccn2)c1[O-].COc1cc(-c2nc3ccccc3s2)cc(CN(C)Cc2ccccn2)c1[O-].[Cu+2].
What is the InChIKey of Copper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate)?
The InChIKey is MCEIGWQQZDDKGS-UHFFFAOYSA-L. The full InChI is InChI=1S/2C22H21N3O2S.Cu/c2*1-25(14-17-7-5-6-10-23-17)13-16-11-15(12-19(27-2)21(16)26)22-24-18-8-3-4-9-20(18)28-22;/h2*3-12,26H,13-14H2,1-2H3;/q;;+2/p-2.
What are the key properties of Copper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate)?
Copper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate) has a molecular weight of 844.52 g/mol, XLogP of 8.14, 12 rotatable bonds, 0 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for Copper bis(4-(1,3-benzothiazol-2-yl)-2-methoxy-6-[[methyl(pyridin-2-ylmethyl)amino]methyl]phenolate) is sourced from PubChem (CID 139121066), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.